Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation

Journal of Child Neurology

Volumn 14, Issue 4, 1999, Pages 222-228

  Kapaun, Petra ^a   Dittmann, Ralf W ^a   Granitzny, Barbara ^a   Eickhoff, Wilhelm ^a   Wulbrand, Henning ^a   Neumaier Probst, Eva ^a   Zander, Axel ^a   Kohlschüetter, Alfried ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSIDE SULFATASE;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; HUMAN; METACHROMATIC LEUKODYSTROPHY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0032910380     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400402     Document Type: Article

References (35)

1. Neufeld EF: The uptake of enzymes into lysosomes: An overview. Birth Defects 1980;16:77-84.
2. Hoogerbrugge PM, Brouwer OF, Bordigoni P, et al: Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation. Lancet 1995;345: 1398-1402.
3. Krivit W, Lockman LA, Watkins PA, et al: The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inher Metab Dis 1995;18:398-412.
4. Hoogerbrugge PM, Suzuki K, Suzuki K, et al: Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 1988;239:1035-1038.
5. Birkenmeier EH, Barker JE, Vogler CA, et al: Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 1991;78:3081-3092.
6. Bou-Gharios G, Adams G, Pace P, et al: Correction of a lysosomal deficiency by contact-mediated enzyme transfer after bone marrow transplantation. Transplantation 1993;56:991-996.
7. Walkley SU, Thrall MA, Dobrenis K, et al: Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci U S A 1994;91:2970-2974.
8. Krivit W, Sung JH, Shapiro EG, Lockman LA: Microglia: The effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant 1995;4:385-392.
9. Walkley SU, Dobrenis K: Bone marrow transplantation for lysosomal diseases, comment. Lancet 1995;345:1382-1383.
10. Krivit W, Lipton ME, Lockman LA, et al: Prevention of deterioration in metachromatic leukodystrophy by bone marrow transplantation. Am J Med Sci 1987;294:80-85.
11. Krivit W, Shapiro E, Kennedy W, et al: Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation, comments. N Engl J Med 1990;322:28-32.
12. Dhuna A, Toro C, Torres F, et al: Longitudinal neurophysiologic studies in a patient with metachromatic leukodystrophy following bone marrow transplantation. Arch Neurol 1992;49:1088-1092.
13. Shapiro EG, Lockman LA, Balthazor M, Krivit W: Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995;18:413-429.
14. Pridjian G, Humbert J, Willis J, Shapiro E: Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation. J Pediatr 1994;125:755-758.
15. Malm G, Ringden O, Winiarski J, et al: Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant 1996;17: 1003-1008.
16. Bayever E, Ladisch S, Philippart M, et al: Bone-marrow transplantation for metachromatic leucodystrophy. Lancet 1985;2: 471-473.
17. Imaizumi M, Gushi K, Kurobane I, et al: Long-term effects of bone marrow transplantation for inborn errors of metabolism: A study of four patients with lysosomal storage diseases. Acta Paediatr Jpn 1994;36:30-36.
18. Stillman AE, Krivit W, Shapiro E, et al: Serial MR after bone marrow transplantation in two patients with metachromatic leukodystrophy. Am J Neuroradiol 1994;15:1929-1932.
19. Guffon N, Souillet G, Maire I, et al: Juvenile metachromatic leukodystrophy: Neurological outcome two years after bone marrow transplantation. J Inherit Metab Dis 1995;18:159-161.
20. Navarro C, Fernandez JM, Dominguez C, et al: Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation; a 4-year follow-up study. Neurology 1996;46:254-256.
21. von Figura K, Steckel F, Hasilik A: Juvenile and adult metachromatic leukodystrophy: Partial restoration of arylsulfatase A activity by inhibitors of thiol proteinases. Proc Natl Acad Sci U S A 1983;80:6066-6070.
22. Kappler J, Leinekugel P, Conzelmann E, et al: Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency. Hum Genet 1991;86:463-470.
23. Polten A, Fluharty AL, Fluharty CB, et al: Molecular basis of different forms of metachromatic leukodystrophy, comment. N Engl J Med 1991;324:18-22.
24. Demaerel P, Faubert C, Wilms G, et al: MR findings in leukodystrophy. Neuroradiology 1991;33:368-371.
25. Wechsler D: Wechsler Intelligence Scale for Children - Revised. San Antonio, TX: Psychological Corp, 1973.
26. Hyde TM, Ziegler JC, Weinberger DR: Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis, comment. Arch Neurol 1992;49:401-406.
27. Kolodny EH, Fluharty AL: Metachromatic leukodystrophy and multiple sulfatase deficiency: Sulfatide lipidosis, in Scriver CR, Beaudet AL, Sly WS, et al (eds): The Metabolic and Molecular Basis of Inherited Disease, 7th ed, vol 2. New York, McGraw-Hill, 1995, pp 2693-2739.
28. Kreysing J, von Figura K, Gieselmann V: Structure of the human arylsulphatase A gene. Eur J Biochem 1990;191:627-631.
29. Gieselmann V, Zlotogora J, Harris A, et al: Molecular genetics of metachromatic leukodystrophy. Hum Mutat 1994;4:233-242.
30. Barth ML, Fensom A, Harris A: Identification of seven novel mutations associated with metachromatic leukodystrophy. Hum Mutat 1995;6:170-176.
31. Leinekugel P, Michel S, Conzelmann E, Sandhoff K: Quantitative correlation between the residual activity of ß-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 1992;88:513-523.
32. Penzien JM, Kappler J, Herschkowitz N, et al: Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease. Am J Hum Genet 1993;52:557-564.
33. Shapiro EG, Lockman LA, Knopman D, Krivit W: Characteristics of the dementia in late-onset metachromatic leukodystrophy. Neurology 1994;44:662-665.
34. Kidd D, Nelson J, Jones F, et al: Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol 1998;55:98-99.
35. Peters C, Waye JS, Vellodi A, et al: Hematopoietic stem cell transplantation for metachromatic leukodystrophy prior to onset of clinical signs and symptoms, in Ringden O, Hobbs JR, Stewart CG (eds): Correction of Genetic Diseases by Transplantation 1997. London, COGENT, 1997, pp 34-48.